InspireMD (NSPR) Restructuring Costs (2015 - 2025)
InspireMD (NSPR) reported Restructuring Costs of $1.3 million for Q4 2025, up 21.29% on a YoY basis from $1.1 million in Q4 2024, and down 29.02% quarter-over-quarter from $1.8 million in Q3 2025.
InspireMD (NSPR) Restructuring Costs (2015 - 2025) Analysis & Trends
InspireMD has reported Restructuring Costs for 3 years, with the latest figure at $1.3 million in Q4 2025.
- For the quarter ending Q4 2025, Restructuring Costs rose 21.29% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2025 stood at $6.3 million (up 38.12% YoY), and the FY2025 full-year result was $6.4 million, up 37.72% from the prior year.
- Restructuring Costs for Q4 2025 stood at $1.3 million, down from $1.8 million in the prior quarter.
- The five-year high for Restructuring Costs was $1.8 million in Q3 2025, with the low at $1.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | InspireMD | 45.74 Mn | -8.48 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2015 | 18,000.00 |
| Sep 30, 2015 | 418,000.00 |
| Jun 30, 2015 | 32,000.00 |